Your cart

There are no items in your shopping cart

Bisindolylmaleimide IV - Arcyriarubin A

Based on 530 reference(s) in Google Scholar 8 10 530

Axon 3939

CAS [119139-23-0]

MF C20H13N3O2
MW 327.34

  • Purity: 98%
  • Soluble in DMSO and EtOH

Bisindolylmaleimide IV

Description

Bisindolylmaleimide IV is a potent inhibitor of protein kinase C with an IC50 value of 0.55 μM.

Keywords: Bisindolylmaleimide IV | Supplier | PKC inhibitor | Arcyriarubin A | Ro 31-6233 | Ro31-6233 | Ro-31-6233 | CAS [119139-23-0] | Non Selective (Phosphorylation substrates) | PKC | Inhibitor | Enzymes

Order
Size Unit Price Stock
10 mg €120.00 In Stock
50 mg €480.00 In Stock
Need more? Bulk Inquiry

Related Products

Axon ID Name Description From price
1401 LY 333531 mesylate PKC-β inhibitor €80.00
1635 Sotrastaurin PKC inhibitor €50.00
2362 LY 333531 hydrochloride PKC-β inhibitor €80.00
1682 Enzastaurin PKC-β inhibitor €95.00
2466 Gö 6983 Broad spectrum PKC inhibitor lacking inhibitory effect for PKCμ €90.00
5010 Naive Stem Cell NHSM inhibitor Set Set of inhibitors for isolation, generation, derivatization and stabilization of naive hPSCs €230.00
2656 CRT0066854 Selective ATP-competitive inhibitor of the atypical PKC isoenzymes €135.00
2981 B106 Potent and selective PKC-δ inhibitor €135.00
2717 Apigenin Selective inhibitor of Casein kinase 2 (CK2) €70.00
3851 LXS-196 Potent and selective protein kinase C inhibitor Inquire
3986 N-Desmethyltamoxifen hydrochloride Metabolite of Tamoxifen (Axon 3252); PKC inhibitor €180.00

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Newsletter
Give Feedback
 
Send E-mail

Customer Support

About Axon Medchem

Download Product Catalog

Download the Axon Ligands™ catalogue 2025 Spring Edition

Follow Us

© 2016 Axon Medchem. All Rights Reserved.

Send us a message

×

Contact Us

* Required Fields

Please wait...